Purslane – The Gourmet Weed
Health benefits of Purslane This wonderful green leafy vegetable is very low in calories (just 16 kcal/100g) and fats; nonetheless, it is rich in dietary fiber, vitamins, and minerals. Fresh leaves...
View ArticleRilpivirine
Rilpivirine 500287-72-9 cas no 4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile Rilpivirine (TMC278, trade name Edurant) is a pharmaceutical drug, developed...
View ArticleUS HERBS –DAMIANA, reported to be an aphrodisiac, stimulant, mood elevator
Damiana Damiana (Turnera diffusa) is reported to be an aphrodisiac, stimulant, mood elevator, and “tonic,” and has been in use in the United States since 1874. Despite a paucity of research, it has...
View ArticleUS Approves Breakthrough Hepatitis C Drug, Sofosbuvir » All About Drugs
US Approves Breakthrough Hepatitis C Drug, Sofosbuvir » All About Drugs amcrasto@gmail.com Filed under: Uncategorized Tagged: Sofosbuvir
View ArticleBaxter seeks FDA approval of Rixubis in paediatric hemophilia B patients
Baxter International has filed an application to the US Food and Drug Administration (FDA) for a paediatric indication for Rixubis, Coagulation Factor IX (Recombinant), for the treatment of...
View ArticleAnakinra licensed in UK to treat CAPS in infants and adults
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has granted a licence to an interleukin-1 (IL-1) inhibitor Anakinra (Kineret) for the treatment of cryopyrin-associated...
View ArticleNew Drug Application for Belinostat in Relapsed or Refractory PTCL Submitted...
Copenhagen, December 10, 2013 — Topotarget announces the submission of a New Drug Application (NDA) for belinostat for the treatment of relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL)...
View ArticleSanfilippo Syndrome: Gene Therapy Developments
Reblogged from : Gene therapy for rare genetic diseases continues to top the news in biotechnology. Biotechnology companies that develop and commercialize gene therapy is a rapidly growing field of...
View ArticleWorld Drug Tracker: J&J provides siltuximab regulatory update, reports Phase...
World Drug Tracker: J&J provides siltuximab regulatory update, reports Phase II data Filed under: Uncategorized Tagged: monoclonal antibody, phase 2, siltuximab
View ArticleApproval of Abraxane for Late-Stage Pancreatic Cancer
Reblogged from AAPS Blog: Abimbola Farinde, Pharm.D., is a clinical pharmacist specialist with specializations in psychopharmacology and geriatrics. The Food and Drug Administration’s (FDA) approval...
View ArticleSprout Pharmaceuticals Appeals FDA Decision on NDA for Flibanserin to Treat...
Flibanserin, girosa 167933-07-5 cas no 147359-76-0 (monoHCl) Flibanserin, BIMT-17-BS, BIMT-17 1 – [2 - [4 - [3 - (Trifluoromethyl) phenyl] piperazin-1-yl] ethyl] -2,3-dihydro-1H-benzimidazol-2-one...
View ArticleScinoPharma’s $113 million China API plant is ready to go
Western drugmakers aren’t the only ones building new plants in China. Taiwan’s ScinoPharm has just finished up a $113 million facility to make active pharmaceutical ingredients (APIs) for China, as...
View ArticleTandospirone » All About Drugs
Tandospirone » All About DrugsFiled under: Uncategorized Tagged: TANDOSPIRONE
View ArticleCHYAVAN PRASH ; AN EXCELLENT AYURVEDA PREPARATION FOR ALL AGES TO BE TAKEN IN...
Reblogged from आयुर्वेद : ई०टी०जी० आयुर्वेदास्कैन : AYURVEDA : ETG AyurvedaScan ; ई० एच० जी० होम्योपैथीस्कैन : E.H.G. HomoeopathyScan: AYURVEDA, the Indian System of Medicine have full of hundreds of...
View ArticleMerck Statement on FDA Advisory Committee for GRASTEK® (Timothy Grass Pollen...
pollen An allergen is a type of antigen that produces an abnormally vigorous immune response in which the immune system fights off a perceived threat that would otherwise be harmless to the body. Such...
View ArticleHOMEOPATHY…… ALLERGY TREATMENT, GRASS POLLEN
click http://www.iherb.com/NatraBio-bioAllers-Allergy-Treatment-Grass-Pollen-1-fl-oz-30-ml/6660 Filed under: HOMEOPATHY Tagged: ALLERGY, GRASS POLLEN, HOMEOPATHY
View ArticleThe US Food and Drug Administration (FDA) has granted a six-month Priority...
13 dec 2013 Genzyme’s Cerdelga NDA receives US FDA priority review designationpharmabiz.comThe US Food and Drug Administration (FDA) has granted a six-month Priority Review designation to Genzyme’s New...
View ArticleMedicinal Chemistry International
Medicinal Chemistry InternationalFiled under: Uncategorized Tagged: TAMOXIFEN
View Article